{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_651", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "omen in the second trimester, irrespective of the \nproven presence of helminthiasis; baseline prevalence \nwas 15%, 38% and 6% for ascariasis, hookworm and \ntrichuriasis, respectively. The other Ugandan RCT \ncontributed data on albendazole plus ivermectin \nversus ivermectin only, administered as single doses \nto pregnant women in the second trimester; all \nwomen were infected with an intestinal helminth at \ntrial entry.\nMaternal outcomes\nLow-certainty evidence suggests that a single dose of \nalbe"}